Literature DB >> 857758

Jejunoileal bypass as a treatment of morbid obesity.

J M Campbell, T K Hunt, J H Karam, P H Forsham.   

Abstract

Seventy-five morbidly obese patients underwent jejunoileal bypass between December 1968 and October 1975. The average weight of 45 patients who had had the bypasses for over two years stabilized at 62.4% of the maximum preoperative value. Postoperative complications included recurrent diarrhea in 11% (8/74) and serum electrolyte deficits in 64% (48/75), most of which were transient. Potassium and calcium deficiencies were usually correctable by oral supplementation, but hypomagnesemia persisted in 23% (16/71) despite supplementation. Nine percent (4/43) had biopsy-proved hepatic cirrhosis after one year. Other complications were polyarthralgia, bone demineralization, renal stones, and vasculitis. Three patients required reanastomosis to original bowel continuity; all rapidly regained weight. One died of vasculitis and hepatic failure attributable to the bypass. Jejunoileal bypass is suitable only in morbidly obese patients with particularly high motivation, whose risk factors outweigh those risks incurred through bypass.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 857758

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  9 in total

1.  Post biliopancreatic bypass arthritis. Dermatitis syndrome.

Authors:  F P Cantatore; M Carrozzo; M C Loperfido
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

2.  Nonalcoholic Steatohepatitis.

Authors:  Brian P Mulhall; Zobair M Younossi
Journal:  Curr Treat Options Gastroenterol       Date:  2004-12

Review 3.  Treatment of non-alcoholic fatty liver disease.

Authors:  L A Adams; P Angulo
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

4.  Spondyloarthritis after bariatric surgery: is there a link?

Authors:  Daniel Sá Ribeiro; João Luiz Fernandes; Leandro Rangel; César de Araújo Neto; Fernando D'Almeida; Carlos Geraldo Moura; Mittermayer B Santiago
Journal:  Clin Rheumatol       Date:  2010-01-22       Impact factor: 2.980

Review 5.  Pathogenesis and management issues for non-alcoholic fatty liver disease.

Authors:  Marko Duvnjak; Ivan Lerotić; Neven Barsić; Vedran Tomasić; Lucija Virović Jukić; Vedran Velagić
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

6.  Vitamin D and bone mineral content after intestinal bypass operation for obesity.

Authors:  H Rickers; C Christiansen; I Balslev; H Foltved; P Rødbro; M S Christensen
Journal:  Gut       Date:  1983-01       Impact factor: 23.059

7.  Current treatments in nonalcoholic steatohepatitis.

Authors:  Dawn M Torres; Stephen A Harrison
Journal:  Curr Treat Options Gastroenterol       Date:  2007-12

8.  Delayed fracture healing following jejunoileal bypass surgery for obesity.

Authors:  H Hey; B Lund; O H Sørensen; B Lund
Journal:  Calcif Tissue Int       Date:  1982-01       Impact factor: 4.333

9.  Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease.

Authors:  M S Mirza
Journal:  ISRN Gastroenterol       Date:  2011-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.